Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells
Abstract Cancer therapy is often hampered by the disease’s development of resistance to anticancer drugs. We previously showed that the autonomously upregulated product of fibroblast growth factor 13 gene (FGF13; also known as FGF homologous factor 2 (FHF2)) is responsible for the cisplatin resistan...
Guardado en:
Autores principales: | Nobuki Matsumoto, Miku Ebihara, Shiori Oishi, Yuku Fujimoto, Tomoko Okada, Toru Imamura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/911c5b64f856425d9341c0446eb9ffee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Histamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis
por: Kyoung-Woon Kim, et al.
Publicado: (2017) -
Structures 4-n-propyl Piperazines as Non-Imidazole Histamine H3 Antagonists
por: Andrzej Olczak, et al.
Publicado: (2021) -
Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats
por: Alachkar A, et al.
Publicado: (2019) -
Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Myung Jin Song, et al.
Publicado: (2021) -
The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis.
por: Imad M Tleyjeh, et al.
Publicado: (2013)